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Genetic factors play a significant role in the etiology of intellectual disability (ID). The goal of this study was to
identify microscopically visible chromosomal abnormalities in an Indonesian ID population and to determine
their frequency, pattern, and clinical features. A total of 527 intellectually disabled individuals from special
schools and institutions in 4 different areas on Java Island, Indonesia, were screened for cytogenetic abnor-
malities. Additional analyses were carried out for verification or further characterization by using fluorescence
in situ hybridization, multiplex ligation-dependent probe amplification, or analysis of the FMR1 promoter
CGG(n) repeat. Of the 527 individuals with ID, chromosomal abnormalities were found in 87 (16.5%). Trisomy
21 was the major chromosomal abnormality, identified in 74 patients (14%). Other chromosome abnormalities
included 8 X-chromosomal and 5 autosomal aberrations. Details on chromosome aberrations and confirmation
analyses are discussed. This study shows that chromosomal abnormalities are an important cause of ID in
Indonesia. Cytogenetic analysis is important for an adequate diagnosis in patients and subsequent genetic
counseling for their families, especially in developing countries with limited facilities, such as Indonesia.
Intellectual disability (ID) is a major health problemworldwide. In addition to health problems, individuals
with ID need more educational and psychological attention.
Moreover, most of those with severe ID require lifelong
nursing, guidance, and surveillance (Schalock et al., 2007).
Known causes of ID are biochemical and metabolic defects,
chromosomal abnormalities, mutations in single genes
(Mendelian disorders and mitochondrial disorders), multi-
factorial disorders with a polygenic predisposition, and non-
genetic causes (Chiurazzi and Oostra, 2000; van Karnebeek
et al., 2005). Pathogenic chromosomal abnormalities are the
most common genetic cause of ID (Stevenson et al., 2003;
Mefford, 2009). Microscopically visible numeric and struc-
tural abnormalities account for 7–56% of cases depending on
techniques used and patient selection (Fryns et al., 1986; De-
reymaeker et al., 1988; Fryns et al., 1990; Felix et al., 1998;
Santos et al., 2000; van Karnebeek et al., 2002; Shiue et al., 2004;
Dayakar et al., 2010). Down syndrome is the most common
chromosomal abnormality causing ID, and it can be easily
detected by using routine chromosomal analysis (Tolmie and
MacFayden, 2007).
To date, there are few data on the incidence and cause of ID
in Indonesia, even though approximately 66,500 pupils have
been registered in special schools for intellectually disabled
individuals (Kemendiknas 2010). This number, however, is
far lower than the total number of ID individuals in Indonesia.
Cytogenetic analysis has not been recognized as a routine
diagnostic tool for patients with ID in Indonesia, although the
technique is available. Furthermore, genetic disorders have
not received much attention from the government and med-
ical practitioners, partly because the main health problems for
childhood morbidity and mortality are socioeconomic and
environmental, such as malnutrition and infection.
Previous studies in the Indonesian ID population primarily
focused on the fragile X syndrome (Hussein, 1998; Faradz
et al., 1999). Therefore, this study aimed to determine the
prevalence and pattern of microscopically visible chromo-
somal abnormalities and the clinical features of positive cases
in ID individuals in Indonesia.
Materials and Methods
Patient selection and setting
A total of 527 participants (329males and 198 females) were
included in the study. Their ages ranged from 6 to 25 years,
and they were from 4 different places on Java Island, In-
donesia (Semarang, Temanggung, Yogyakarta, and Ban-
dung). Of the 527 patients, 156 were institutionalized and 371
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attended special schools. The majority of the individuals
(n = 345) appeared to be mildly intellectually disabled, 161
were moderately disabled, and 21 were severely disabled
(Table 1). Informed consent was obtained from the parents or
legal representatives, and the study was approved by the
Ethical Board of the University of Diponegoro/Kariadi Hos-
pital Semarang, Indonesia. All participants underwent a
standardized clinical examination before blood was drawn.
This examination comprised physical measurements and
dysmorphologic assessment.
Peripheral blood samples were collected from December
2006 to November 2008, and cytogenetic analysis was
performed on all 527 samples. Structural abnormalities
were confirmed by multiplex ligation-dependent probe
amplification (MLPA) or fluorescence in situ hybridization
(FISH). Southern blot analysis was carried out to confirm
the presence of cytogenetically visible fragile sites on the X
chromosome.
Chromosome cultures and preparations were carried out
as described elsewhere (Blennow 2005). One hundred
metaphases were screened for fragile sites on each sample.
Subsequently, chromosome analysis was performed by
using G-banding technique on the level of 400–600 bands.
At least 20 metaphases were scored for each patient and
karyotyped. If a mosaicism was suspected, 50–100 cells
were counted.
FISH analysis was performed by using commercially
available probes (Vysis, Inc., Downers Grove, IL) according to
standard protocols as previously described (de Bruijn et al.,
2001). Genomic DNAof each patientwas isolated by using the
salting-out method (Miller et al., 1988). MLPA analysis was
performed as described elsewhere (Schouten et al., 2002;
Koolen et al., 2004). Several probe kits from MRC-Holland
(Amsterdam, the Netherlands) were used in these experi-
ments: SALSA P036D and SALSA P070 (probes specifically
designed for subtelomeric chromosomal imbalances), SALSA
P096 (probes for several ID syndromes), and SALSA P028
(methylation-specific probes for chromosome 15).
Southern blot analysis of the FMR1 CGG(n) repeat was
performed as described previously (Oostra et al., 1993; Smits
et al., 1994).
Results
Chromosomal abnormalities were found in 87 (16.5%) of
the 527 intellectually disabled individuals. Trisomy 21was the
major chromosomal abnormality, occurring in 74 cases (14%).
The latter cases consisted of 71 with full-blown classical tri-
somy 21 (43 males and 28 females), 2 with a mosaicism of
trisomy 21 [47,XX,+ 21(73)/46,XX(27) and 47,XY + 21(65)/
46,XY(35), respectively] (Table 2), and 1 with a Robertsonian
translocation (46,XX,der(14;21)(q10;q10), + 21) (Table 3, case
1). The latter patient’s mother’s karyotype was normal, and
her father’s sample was not available. Therefore, we could not
determine whether this translocation was de novo or inherited
from her father.
In 13 cases, chromosomal abnormalities other than Down
syndromeweredetected.Twoparticipants hadX-chromosomal
aneuploidies (45,X(10)/46,XX(90) and 47,XXX; Table 2). For
both females the chromosomal aberration detected is not a
satisfactory explanation for their moderate ID. The other 11
cases showed structural chromosome aberrations (cases 2–12,
Table 3).
Apart from the t(14;21) case, autosomal structural abnor-
malities were found in 5 cases (1.0%): 2 unbalanced trans-
locations, 1 balanced translocation, 1 deletion, and 1 isodicentric
chromosome. No further confirmation test was performed on
the Down syndrome cases, the cases with an X-chromosomal
aneuploidy (Table 2), or a case with a large visible terminal Xq
deletion (case 7). Five samples from 4 males and 1 female
patient were identified to have a fragile site at Xq27.3 (cases 8–
12). Southern blot analysis confirmed the presence of a fully
methylated expansion ( > 200 CGG repeats) in the promoter
region of the FMR1 gene in each of the 5 cases.
MLPA or FISH analysis was used to confirm the structural
chromosomal abnormalities in cases with autosomal aberra-
tions (cases 2–6). Whole chromosome paints of chromosome
18 confirmed a missing part of chromosome 18 in the sample
of the patient with 46,XX,del(18)(q21.3/qter)dn (case 2).
Further analysis using an 18q telomere FISH probe detected
only 1 signal from chromosome 18. Her parent’s karyotypes
were normal, confirming de novo occurrence. This patient had
clinical features resembling those of previously described
patients with a similar chromosomal aberration (Kimpen
et al., 1991; Kline et al., 1993) (Fig. 1).
In case 3, cytogenetic analysis revealed 46,XY,del(4)(p16).
However, confirmation with MLPA analysis demonstrated
not only a deletion of chromosome 4pter but also a duplication
of 8pter (SALSA MLPA kits P036D and P070). Afterwards,
FISH was performed by using probes for the subtelomeric
regions of chromosome 4p and 8p; indeed, only 1 signal for
4pter and 3 signals for 8pter (1 of which was on the derivative
Table 1. Characteristics of the Study Population
Characteristic Participants (n)
Sex
Male 329
Female 198
Area/city
Semarang 327
Temanggung 134
Yogyakarta 11
Bandung 55
School type
Institution 156
Special school 371
ID severity
Mild 345
Moderate 161
Severe 21
ID, intellectual disability.
Table 2. Numerical Chromosome Aberrations
Detected in 527 Intellectually Disabled
Indonesian Individuals
Chromosomal abnormality Karyotype Cases (n)
Down syndrome 47,XX,+ 21 28
47,XY,+ 21 43
47,XX,+ 21(73)/46,XX(27) 1
47,XY,+ 21(65)/46,XY(35) 1
Turner syndrome 45,X(10)/46,XX(90) 1
Other X aneuploidy 47,XXX 1
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chromosome 4) were detected. Both parents showed normal
karyotypes, and carriership of a balanced translocation has
been excluded. Therefore, the karyotype of the patient should
be designated as 46,XY,der(4)t(4:8)(p16;p23)dn. Further char-
acterization was performed with MLPA analysis by using
several probes from the Wolf–Hirschhorn syndrome critical
region (WHSCR) (SALSA MLPA kit P096). This analysis re-
vealed a deletion of the entire WHSCR. The cytogenetic and
molecular analyses confirmed the clinical diagnosis of Wolf-
Hirschhorn syndrome (Fig. 1).
In case 4, cytogenetic analysis revealed a karyotype of
46,XX,add(10)(q26). However, MLPA demonstrated a deletion
of chromosome 10qter and a duplication of 4pter. Subsequently,
FISH was performed by using probes for the subtelomeric re-
gions of chromosome 10q and 4p. Only 1 signal for 10qter and 3
signals for 4pter (1 of which was on the aberrant chromosome
10q) were detected. Consequently, the karyotype of the patient
should be designated as: 46,XX,der(10)t(4:10)(p16;q26). Un-
fortunately, this patient’s parents were unavailable for testing.
Because 4pter duplications are reported in patients with and
without ID and distinctive facial features (Gerard-Blanluet et al.,
2004; Rodriguez et al., 2007), it is suggested that the phenotype
in case 4 most likely is due to the deletion of 10qter. The clinical
features of this patient are in concordance with the consistent
phenotype of patients with a 10q26.1qter deletion, as described
by de Vries et al. (2003) (Fig. 1).
In case 5 (Fig. 1), in which chromosome analysis revealed a
46,XX,t(3;12)(p14.1;q21.2) karyotype, further confirmation
usingMLPA showed a normal result. It is therefore suggested
that the aberration was a (cytogenetically) balanced translo-
cation. Neither parent was available for testing. In case 6 cy-
togenetic analysis showed a 47,XY,idic(15)(q13). MLPA
analysis of probes in the 15q11.2-15q15.1 region (MRC Hol-
land kit P028) showed 4 copies of the probes between BP1 and
BP4 (including TUBGCP5 and TJP1) and 3 copies of the probes
in the TRPM1, KLF13, and CHRNA7 genes (between BP4 and
BP5) (Miller et al., 2009). The methylation-specific analysis
indicated that the marker was of maternal origin. The pa-
tient’s parents were unavailable for testing. Clinical features
were severe ID, epilepsy, and very poor language expression,
which are in fact the main features of isodicentric (15) syn-
drome (Battaglia 2008) (Fig. 1).
Case 7 had a deletion of part of the long arm of 1 of her X
chromosomes [46,X,del(X)(q21/qter)]. She had mild ID and
Table 3. Structural Chromosome Aberrations Detected in 527 Intellectually Disabled Indonesian Individuals
Case no. Karyotype Molecular confirmation Parents
1 46,XX,der(14;21)(q10;q10), + 21 NT Maternal karyotype normal;
paternal karyotype unavailable
2 46,XX,del(18)(q21.3(qter)dn FISH: Del 18qter Normal karyotypes
3 46,XY,der(4)t(4:8)(p16;p23)dn FISH and MLPA: Del4pter/dup8pter Normal karyotypes
4 46,XX,der(10)t(4:10)(p16;q26) FISH and MLPA: Del10q/dup4p NT
5 46,XX t(3;12) (p14.1;q21.2) MLPA: Normal NT
6 47,XY,idic(15)(q13) MLPA: Dup 15 (maternal origin) NT
7 46,XX,del(X)(q21(qter) NT NT
8 46,XY,fra(X)(q27.3) SB, full mutation Mother is premutation carrier
9 46,XX,fra(X)(q27.3) SB, full mutation Mother is premutation carrier
10 46,XY,fra(X)(q27.3) SB, full mutation Mother is premutation carrier
11 46,XY,fra(X)(q27.3) SB, premutation–full mutation (mosaic) Mother is premutation carrier
12 46,XY,fra(X)(q27.3) SB, premutation–full mutation (mosaic) Mother is premutation carrier
FISH, fluorescent in situ hybridization; MLPA, multiplex ligation-dependent probe amplification; NT, not tested; SB= Southern blot
analysis.
FIG. 1. Patients with a chromosomal
abnormality. (A) Case 2. (B) Case 3. (C)
Case 4. (D) Case 5. (E) Case 6. (F) Case 7.
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obvious dysmorphisms (Fig. 1). Females with a similar aber-
ration have been reported to show mostly only mild Turner
stigmata or subtle dysmorphisms, next to ovarian failure. ID,
however, was not reported in these females (Graham et al.,
2007), which makes it unlikely that the chromosomal aber-
ration directly caused the ID in this patient. Further investi-
gations, such as X inactivation studies, are needed.
Four males and 1 female expressed a fragile site on the X
chromosome. Southern blot analysis confirmed that they all
had fragile X syndrome. Three cases (cases 8, 9, and 10) had a
full mutation of FMR1, and 2 (cases 11 and 12) showed a
mosaicism (premutation and full mutation).
After exclusion of individuals with chromosomal aberra-
tions other than fragile X syndrome (82 patients for the whole
population and 46 for the male population), the prevalence of
fragile X syndrome in this study is 1.1% (5 of 445) among the
whole study population and 1.4% (4 of 283) in the male
population.
Discussion
The overall frequency of microscopically visible chromo-
somal aberrations in this study was 16.5%. This is similar to
the rate reported in other studies (13.3%–17.6%) (Fryns et al.,
1986; Dereymaeker et al., 1988; Fryns et al., 1990), although
different frequencies were found in other studies: 7.9% (van
Karnebeek et al., 2002), 22.43% (Shiue et al., 2004), 28.6%
(Santos et al., 2000), 34.2% (Felix et al., 1998), and 56% (Day-
akar et al., 2010). These differences might be due to variations
in inclusion criteria of patients. van Karnebeek and colleagues
found a lower frequency of microscopically visible aberra-
tions, possibly because the study was performed in a tertiary
care center (outpatient clinic) (van Karnebeek et al., 2002).
Some studies generated higher frequencies than our study
(Table 4), and this may have occurred because more pa-
tients with moderate and severe or profound ID were in-
cluded. These differences might also be due to preselection of
cases without known nonchromosomal causes of ID or
multiple congenital anomalies, as was done by Dayakar et al.
(2010).
The male-to-female ratio in our study was 1.66:1, which is
higher than in some previous reports (1.2:1–1.4:1) (Roeleveld
et al., 1997; Partington et al., 2000; Macayran et al., 2006; Lin,
2009) but lower than in other studies, which reported a ratio as
high as 3:1 (Shin and Lee 1999; Tang et al., 2008). The sex ratio
differences might be explained by the differences in selection
and case ascertainment (Roeleveld et al., 1997). Another as-
certainment bias in our setting might be that parents seek
assistance more frequently for boys than for girls because of
generally higher expectations for male children.
Fourteen percent of the intellectually disabled individuals
in this study had Down syndrome. This finding confirms that
the syndrome is the most common chromosomal abnormality
involved in ID. Severe cases, such as trisomy 13 and trisomy
18, were not found in our study, most likely because these
patients died before they reached school age. The prevalence
of Down syndrome in our study is similar to that in previous
studies conducted in the Indonesian population(12–14%)
(Hussein 1998). In addition, the prevalence of Down syn-
drome in our study resembled the frequency of 13–15% re-
ported in a white population (Matilainen et al., 1995; van
Buggenhout et al., 1999). We found a male-to-female ratio of
1.5:1 in Down syndrome cases, which reflects the male excess
in our study population. The proportion of patients with
Down syndrome among all male (43 of 329 [13%]) and all
female (28 of 198 [14%]) participants, however, was similar,
which corresponds to previous reports in this population
(Hussein 1998).
The prevalence for fragile X syndrome in this study was
1.1% (5 of 445) among the whole study population and 1.4% (4
of 283) in the male population. A previous study among in-
tellectually disabled individuals in Indonesia that used mo-
lecular analysis showed a similar prevalence of 1.9% (5 of 262)
in the male population (Faradz et al., 1999). It is also similar to
that reported in some studies of white populations (2–3%) (de
Vries et al., 1997; Hecimovic et al., 2002; Biancalana et al., 2004).
The prevalence could have been higher if molecular analysis
had been performed in all 527 patient samples because not all
carriers of the FRAXA mutation express the fragile site on
karyotyping (Pembrey et al., 2001). However, because of lim-
ited availability of molecular testing in Indonesia, cytogenetic
studies for fragile X are still a useful tool to detect fragile X(A)
and other fragile site abnormalities, including FRAXE, FRAXF,
and fragile sites in autosomes (Hussein 1998).
Our study shows that cytogenetic analysis is still a pow-
erful tool to detect genetic abnormalities in the ID population.
The fact that cytogenetic analysis can now be performed in
Indonesia should be considered by granting agents, such as
government and nonprofit organizations, so that they may
financially support genetic studies in developing countries
Table 4. Frequency of Microscopically Visible Chromosomal Aberrations
in Current Study Compared with Previous Studies
Study (year)
Overall
frequency
Structural
abnormalities
Numeric
abnormalities
Down syndrome in patients
with cytogenetic abnormalities
van Karnebeek et al. (2002) 7.9 (21/266) 4.9 (13/266) 3.0 (8/266) 0 (0/21)
Dereymaeker et al. (1988) 13.3 (21/158) 3.8 (6/158) 9.5 (15/158) 71.4 (15/21)
Fryns et al. (1986) 15.0 (26/173) 2.3 (4/173) 12.7 (22/173) 84.6 (22/26)
Current study 16.5 (87/527) 2.3 (12/527) 14.2 (75/527) 85.1 (74/87)
Fryns et al. (1990) 17.6 (46/262) 1.2 (3/262) 16.4 (43/262) 93.4 (43/46)
Shiue et al. (2004) 22.4 (94/419) 2.6 (11/419) 19.8 (83/419) 81.9 (77/94)
Santos et al. (2000) 28.6 (28/98) 6.1 (6/98) 22.5 (22/98) 42.9 (12/28)
Felix et al. (1998) 34.2 (69/202) 1.5 (3/202) 32.7 (66/202) 94.2 (65/69)
Dhayakar et al. (2010) 56 (56/100) 11 (11/100) 45 (45/100) 51.78 (29/56)
Data are expressed as % (n/n).
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such as Indonesia. Furthermore, because common infectious
diseases and nutritional problems are becoming less prevalent
in Indonesia, diagnostic facilities for genetic diseases must
receive a higher priority. Such efforts would extend genetic
analysis to more diverse populations than normally studied
(Bustamante et al., 2011).
Conclusions
Chromosomal abnormalities play an important causative
role in ID in Indonesia. However, because cytogenetic anal-
ysis is still not commonly performed in intellectually disabled
individuals in Indonesia, the implementation of this tech-
nique in a routine diagnostic setting will help to establish a
genetic diagnosis in the local setting and will improve the
possibilities for genetic counseling to the families.
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